Role of Ischemic Preconditioning and Inflammatory Response in the Development of Malignant Ventricular Arrhythmias After Reperfused ST-Elevation Myocardial Infarction

Journal of Cardiac Failure

Volumn 15, Issue 9, 2009, Pages 775-781

  Kaneko, Hidehiro ^a   Anzai, Toshihisa ^a   Naito, Kotaro ^a   Kohno, Takashi ^a   Maekawa, Yuichiro ^a   Takahashi, Toshiyuki ^a   Kawamura, Akio ^a   Yoshikawa, Tsutomu ^a   Ogawa, Satoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ischemic preconditioning; post infarction inflammation; Ventricular arrhythmia

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; ST SEGMENT ELEVATION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR;

EID: 70350564900     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.05.001     Document Type: Article

References (33)

1. Lowel H., Dobson A., Keil U., Herman B., Hobbs M.S., Stewart A., et al. Coronary heart disease case fatality in four countries. A community study. The Acute Myocardial Infarction Register Teams of Auckland, Augsburg, Bremen, FINMONICA, Newcastle, and Perth. Circulation 88 (1993) 2524-2531
2. O'Doherty M., Tayler D.I., Quinn E., Vincent R., and Chamberlain D.A. Five hundred patients with myocardial infarction monitored within one hour of symptoms. Br Med J (Clinical Research ed) 286 (1983) 1405-1408
3. Takahashi T., Anzai T., Yoshikawa T., Asakura Y., Ishikawa S., Mitamura H., et al. Absence of preinfarction angina is associated with a risk of no-reflow phenomenon after primary coronary angioplasty for a first anterior wall acute myocardial infarction. Int J Cardiol 75 (2000) 253-260
4. Takahashi T., Anzai T., Yoshikawa T., Maekawa Y., Asakura Y., Satoh T., et al. Effect of preinfarction angina pectoris on ST-segment resolution after primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 90 (2002) 465-469
5. Kharbanda R.K., Peters M., Walton B., Kattenhorn M., Mullen M., Klein N., et al. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation 103 (2001) 1624-1630
6. Beauchamp P., Richard V., Tamion F., Lallemand F., Lebreton J.P., Vaudry H., et al. Protective effects of preconditioning in cultured rat endothelial cells: effects on neutrophil adhesion and expression of ICAM-1 after anoxia and reoxygenation. Circulation 100 (1999) 541-546
7. Newby K.H., Thompson T., Stebbins A., Topol E.J., Califf R.M., and Natale A. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. Circulation 98 (1998) 2567-2573
8. Anzai T., Yoshikawa T., Asakura Y., Abe S., Akaishi M., Mitamura H., et al. Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after a first Q wave myocardial infarction. Journal of the American College of Cardiology 26 (1995) 319-327
9. Anzai T., Yoshikawa T., Shiraki H., Asakura Y., Akaishi M., Mitamura H., et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 96 (1997) 778-784
10. Takahashi T., Anzai T., Yoshikawa T., Maekawa Y., Asakura Y., Satoh T., et al. Serum C-reactive protein elevation in left ventricular remodeling after acute myocardial infarction-role of neurohormones and cytokines. Int J Cardiol 88 (2003) 257-265
11. Maekawa Y., Anzai T., Yoshikawa T., Asakura Y., Takahashi T., Ishikawa S., et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol 39 (2002) 241-246
12. Shiraki H., Yoshikawa T., Anzai T., Negishi K., Takahashi T., Asakura Y., et al. Association between preinfarction angina and a lower risk of right ventricular infarction. N Engl J Med 338 (1998) 941-947
13. Killip III T., and Kimball J.T. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 20 (1967) 457-464
14. Forrester J.S., Diamond G., Chatterjee K., and Swan H.J. Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts). N Engl J Med 295 (1976) 1356-1362
15. Adgey A.A., Allen J.D., Geddes J.S., James R.G., Webb S.W., Zaidi S.A., et al. Acute phase of myocardial infarction. Lancet 2 (1971) 501-504
16. Volpi A., Cavalli A., Santoro L., and Negri E. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction-results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database. Am J Cardiol 82 (1998) 265-271
17. Matsumura K., Jeremy R.W., Schaper J., and Becker L.C. Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation 97 (1998) 795-804
18. Arai M., Lefer D.J., So T., DiPaula A., Aversano T., and Becker L.C. An anti-CD18 antibody limits infarct size and preserves left ventricular function in dogs with ischemia and 48-hour reperfusion. J Am Coll Cardiol 27 (1996) 1278-1285
19. Akar F.G., Aon M.A., Tomaselli G.F., and O'Rourke B. The mitochondrial origin of postischemic arrhythmias. J Clin Invest 115 (2005) 3527-3535
20. Ottani F., Galvani M., Ferrini D., Sorbello F., Limonetti P., Pantoli D., et al. Prodromal angina limits infarct size. A role for ischemic preconditioning. Circulation 91 (1995) 291-297
21. Iglesias-Garriz I., Corral F., Rodriguez M.A., Garrote C., Montes M., and Sevillano E. Pre-infarction angina elicits greater myocardial viability on reperfusion after myocardial infarction: a dobutamine stress echocardiographic study. J Am Coll Cardiol 37 (2001) 1846-1850
22. Papp R., Gonczi M., Kovacs M., Seprenyi G., and Vegh A. Gap junctional uncoupling plays a trigger role in the antiarrhythmic effect of ischaemic preconditioning. Cardiovasc Res 74 (2007) 396-405
23. Hausenloy D., Wynne A., Duchen M., and Yellon D. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation 109 (2004) 1714-1717
24. Itoh T., Fukami K., Suzuki T., Aoki H., Ohira K., Satoh N., et al. Effect of pre-myocardial infarction angina pectoris on post-myocardial infarction arrhythmias after reperfusion therapy. Am J Cardiol 97 (2006) 1157-1161
25. Anzai T., Yoshikawa T., Kaneko H., Maekawa Y., Iwanaga S., Asakura Y., et al. Association between serum C-reactive protein elevation and left ventricular thrombus formation after first anterior myocardial infarction. Chest 125 (2004) 384-389
26. Aronson D., Boulos M., Suleiman A., Bidoosi S., Agmon Y., Kapeliovich M., et al. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction. Am J Cardiol 100 (2007) 753-757
27. London B., Baker L.C., Lee J.S., Shusterman V., Choi B.R., Kubota T., et al. Calcium-dependent arrhythmias in transgenic mice with heart failure. Am J Physiol Heart Circ Physiol 284 (2003) H431-H441
28. Lee S.H., Chen Y.C., Chen Y.J., Chang S.L., Tai C.T., Wongcharoen W., et al. Tumor necrosis factor-alpha alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes. Life Sci 80 (2007) 1806-1815
29. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol 285 (2003) H579-H588
30. Roberts R., DeMello V., and Sobel B.E. Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation 53 (1976) I204-I206
31. Anzai T., Yoshikawa T., Takahashi T., Maekawa Y., Okabe T., Asakura Y., et al. Early use of beta-blockers is associated with attenuation of serum C-reactive protein elevation and favorable short-term prognosis after acute myocardial infarction. Cardiology 99 (2003) 47-53
32. De Sutter J., Tavernier R., De Buyzere M., Jordaens L., and De Backer G. Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients. J Am Coll Cardiol 36 (2000) 766-772
33. Chiu J.H., Abdelhadi R.H., Chung M.K., Gurm H.S., Marrouche N.F., Saliba W.I., et al. Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator. Am J Cardiol 95 (2005) 490-491